Rimas V. Lukas, MD, Derek A. Wainwright, PhD, Erik Ladomersky, PhD, et al
This review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.
David T. Scadden, MD
Dr. Scadden discusses which blood cancer patients are eligible for stem cell transplantation, as well as the latest advances in the field.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: UBM Medica, a divsion of UBM Americas
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA
Rimas V. Lukas, MD, Derek A. Wainwright, PhD, Erik Ladomersky, PhD, et al
David T. Scadden, MD
